New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Dhurandhar Box Office Collection Day 8 (Friday) Early Trends: Will Ranveer Singh & Akshaye Khanna's Film Hit ₹ 250 Cr Today?
'TCS Is The Most Toxic Work Environment I’ve Ever Experienced': Fresher Vents After 11 Months Of Being Employed
Who Is Salil Arora? Punjab Keeper Makes Heads Turn With Stellar Century Days Before IPL 2026 Auction
Retail Inflation Inches Upto 0.71 Per Cent In November As Food And Fuel Prices Rise; RBI Sees FY26 Growth At 7.3 Pc
